Posted by Michael Wonder on 22 Mar 2022
Hope for quadriplegics as ‘miracle treatment’ gets green light from regulator
21 March 2022 - In a major step forward for treating victims of paralysis, Australian regenerative medicine company Orthocell has won regulatory approval for a groundbreaking nerve repair device.
The news heralds an opportunity for thousands of quadriplegic patients to receive potentially life-changing treatment with the device, Remplir, deemed primarily effective for restoring the use of arms and hands in patients.
